# Intellia Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 16:16 ET
- Period: 2024-06-12
- Accession: 0000950170-24-049875
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000095017024049875/ntla-20240429.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000095017024049875/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000095017024049875/ntla-20240429.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049875. Last ingested by Listed: Nov 2, 2026, 17:17 ET. No prices; not investment advice.